Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer
Background: Heterogeneity of human epidermal growth factor receptor 2 (HER2) expression exists in triple-negative breast cancer (TNBC). The evolution of the HER2 testing algorithm has led to the new classification of the HER2-low category, with unclear clinicopathological and molecular features in A...
Saved in:
| Main Authors: | Cuiyan Yang, Haoyu Wang, Yiwei Tong, Zheng Wang, Xi Sun, Anqi Li, Yujie Lu, Mengyuan Han, Siji Zhu, Lei Dong, Kunwei Shen, Xiaosong Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251353083 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.
by: Ziyao Li, et al.
Published: (2015-01-01) -
Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
by: Kristine Astvatsaturyan, et al.
Published: (2018-01-01) -
Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01) -
DNA Methylation and Demethylation in Triple-Negative Breast Cancer: Associations with Clinicopathological Characteristics and the Chemotherapy Response
by: Kateryna Tarhonska, et al.
Published: (2025-02-01) -
Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
by: Su-Jin Shin, et al.
Published: (2024-11-01)